SurvivorNet on MSN

Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
ZME Science

FDA Approves First New Gonorrhea Treatments In 30 Years

This month, the U.S. Food and Drug Administration cleared two new oral antibiotics for use against gonorrhea: zoliflodacin ...
MyChesCo on MSN

FDA clears five-minute lung cancer shot, redefining EGFR treatment

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...

FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
Clinical Advisor

First-in-Class Oral Antibiotic Nuzolvence Approved for Gonorrhea

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
Pharmabiz

Punjab bars pharmacists from administering injections as IPA pushes national vaccinator training

The ongoing nationwide campaign to formally integrate pharmacists into the immunisation delivery system met a regulatory roadblock this week, as the Punjab Health Systems Corporation (PHSC) issued a ...
Indiatimes

Raj govt to administer injections to prevent anaemia in pregnant women

Jaipur: The health department of Rajasthan will use Ferric Carboxymaltose (FCM) injection to curb anaemia among pregnant women in the state. The department will organise an FCM Pink Drive fortnight ...
Healthline

How to Administer Mounjaro

Mounjaro is a prescription injection that can be used to help manage blood sugar levels in adults with type 2 diabetes. It can be administered as an injection under the skin in your abdomen, thigh, or ...
BioSpace

Alprostadil Injection Market Size to worth USD 347.8 Million by 2032, says Coherent Market Insights

According to Coherent Market Insights, The Global Alprostadil Injection Market is estimated to be valued at USD 212.4 Mn in 2025 and is expected to reach USD 347.8 Mn by 2032, exhibiting a compound ...